TOP STORIES

• BUSINESS AbbVie Japan Set to Join Oncology Fray with CLL Drug, Accelerating FIH Trial Entry
  October 9, 2019

• BUSINESS Wholesalers Working Out Systems to Comply with Promotion Guidelines, Show Mixed Approaches to External Oversight
  October 8, 2019

• REGULATORY As Curtain Rises on Diet, MHLW Aims to Get Amended PMD Bill Enacted in Early November
  October 7, 2019

• BUSINESS All 11 Manufacturers Pull Ranitidine from Shelves, “Class I” Recalls for 9 Firms
  October 4, 2019

• ORGANIZATION PhRMA Chair Urges Japan to Rectify PMP Criteria, Narrow Definition of Innovation
  October 4, 2019

• BUSINESS Novo Nordisk Poised to Cash in on New GLP-1 Agents to Hit 100 Billion Yen Japan Sales
  October 3, 2019

• ORGANIZATION Generic Industry Pondering Specific Proposal to Address Unreasonable Price Rises
  October 2, 2019

• REGULATORY New Detailing Guidelines Go into Full Effect on October 1, Making Supervisory Systems Mandatory
  October 1, 2019

• BUSINESS AZ to Focus on Asthma-COPD Overlap in Marketing Triple-Combo Therapy Breztri, Will Help GPs Make Diagnosis
  September 30, 2019

• BUSINESS Amid Slow Uptake, Sysmex Pitching Its Genomic Profiling via Close Communications with Hospitals, Govt: Exec
  September 27, 2019

• REGULATORY Chuikyo Supports Earlier Price Cuts for Certain Off-Patent Brand-Name Drugs
  September 26, 2019

• ORGANIZATION EFPIA Japan Stresses Safety First and Need for Doctors’ Support on Delisting of OTC-Like Drugs, Notes Good Examples Overseas
  September 25, 2019

• REGULATORY Japan Approves Astellas’ HIF-PH Inhibitor, AbbVie’s Venclexta, Tecentriq’s Breast Cancer Use and More
  September 24, 2019

• BUSINESS SanBio’s Lead Cell Therapy Rides High with FDA’s RMAT Designation for Traumatic Brain Injury
  September 20, 2019

• BUSINESS Japan’s 1st Forteo Biosimilar Nears Market, Mochida Looks at Billion-Yen Sales
  September 19, 2019

• BUSINESS Luring Big Pharma with GPCR Work, Sosei Heptares Treads Its Own Path to Pursue Small Molecule Targets
  September 18, 2019

• BUSINESS Japan Still in Transition towards Comprehensive Genomic Profiling, Health Coverage Would Expand: Chugai Official
  September 17, 2019

• REGULATORY Show Us Concrete Proposals for Drug Pricing Reform: Kyokai Kenpo Director to Pharma
  September 13, 2019

• REGULATORY Both Payer, Doctor Members Want to Expand Comparator PMP Removal Rule, but Mixed on Timing: Chuikyo
  September 12, 2019

• INTERVIEW Pharma Industry Watered Down Original Proposals for Pricing Overhaul, Corrections Necessary: Kenporen Director
  September 12, 2019

ページ

• « 先頭
• ‹ Prev
• …
• 116
• 117
• 118
• 119
• 120
• 121
• 122
• 123
• 124
• …
• Next ›
• 最終 »